Rolf Classon
Chairman
Born 1945. Board member since 2022. Chairman since 2023. Member of Audit Committee
Education and work experience:
Chemical Engineer and Pol.Mag., from Gothenburg University. 40+ years experience in Pharmaceuticals, Med.Tech., Diagnostics, Life Science Tools and Healthcare delivery including roles such as CEO and Chairman.
Other assignments and positions:
Boards: Catalent (NYSE CTLT, Fresenius Medical Care (NYSE, DAX),
Privately held companies:
Metenova AB,Destination Pet Inc.
Shareholding in BICO:
B-shares: 31,000, Ownership: 0,05%, Voting right: 0,04%
Independent in relation to the company and group management and to the company’s major shareholders.
Ulrika Dellby
Vice chairwoman
Born 1966. Board member since 2022. Vice chairwoman since 2023. Chairwoman of remuneration committee and member of audit committee.
Education and work experience:
MBA Stockholm School of Economics. Extensive experience from strategy, business development and M&A. Former partner BCG and partner in Private Equity and more than 15 years of experience as board member in listed and private companies.
Other assignments and positions:
Chairman Fasadgruppen
Member of Lifco, Linc, SJ, Werksta and IVA’s business council.
Shareholding in BICO:
B-shares: 5,000
Independent in relation to the company and group management and to the company’s major shareholders.
Erik Gatenholm
Board member
CEO, Co-founder. Born 1989. CEO since 2016.
Education and work experience:
B.Sc. at Virginia Tech University and a M.Sc. in Innovation & Industrial Management from Gothenburg University. Erik has documented success in biotechnology entrepreneurship with more than 13 years of entrepreneurial experience. Honors include: Forbes 30 Under 30, MIT Review 35 Under 35, and Entrepreneur of the year 2020.
Other board assignments:
Board member of board member of BICO Group AB and chairman of BICO International AB.
Shareholding in BICO:
A-shares: 848,958, B-shares: 8,767,036. Ownership: 15%, Voting right: 22.24%
Dependent in relation to the company and group management and to the company’s major shareholders.
Gerry Mackay
Board member
Born 1962. Board member since 2023.
Education and work experience:
Bachelor of Science Honors degree in biochemistry and a Master’s degree in education from the University of Glasgow. Extensive experience in life science as CEO of BioOutsource, 2009 to 2016 and senior roles in sales and marketing in the American life science company Millipore as well as Member of Sartorius AG’s Executive Board and Head of Marketing, Sales and Services within Lab Products and Services until 2023.
Mr Mackay supports Sartorius in various cross-divisional tasks and initiatives.
Other assignments and positions:
–
Shareholding in BICO:
0 shares
Independent in relation to the Company and its management but dependent in relation to major shareholders.
Bengt Sjöholm
Board member
Born 1953. Board member since 2016. Member of remuneration committee.
Education and work experience:
M.Sc. in electrical engineering from Lund University of Technology. He has been CEO of several Swedish companies such as Tylö and CEO of one of the business areas within the Getinge Group.
Other assignments and positions:
Chairman and CEO of BSJ i Halmstad AB and board member of Avidicare Holding AB, Integrum AB, Handelstriangeln AB, Mentice Ab and Texor AB.
Shareholding in BICO:
B-shares: 343,283, Options: 20,000, Ownership: 0.54%, Voting right: 0.44%
Independent in relation to the company and group management and to the company’s major shareholders.
Helena Skåntorp
Board member
Born 1960. Board member since 2019. Chairman of the Audit Committee.
Education and work experience:
Long experience from leading positions as CEO and CFO, for example for Jarowskij AB and Arla, and Doctoral student at Stockholm School of Economics. She has been a member of boards of listed companies for more than 15 years.
Other assignments and positions:
Chairman of Nielstorp AB, Plint Holding AB and Ljung&Sjöberg Intressenter AB. Board member of ByggPartner i Dalarna AB, Byggpartner Gruppen AB (publ) and MEKO AB.
Shareholding in BICO:
B-shares: 4,000, Options: 40,000
Independent in relation to the company and group management and to the company’s major shareholders.
Susan Tousi
Board member
Born 1969. Board member since 2021.
Education and work experience:
Chief Commercial Officer at Illumina, leading global sales, commercial operations, and commercial strategy and enablement. More than 25 years of R&D and business leadership at Fortune 100 technology companies and within the life sciences industry. Formerly, Corporate Vice President and General Manager for Eastman Kodak’s Consumer Inkjet Systems organization. Prior to joining Kodak, R&D program manager for Phogenix Imaging LLC, a joint venture start-up of Hewlett-Packard and Kodak.
MBA degree from UCLA and an Honors BS in Engineering Science and Mechanics from Pennsylvania State University.
Other assignments and positions:
Executive trustee at the world renowned La Jolla Playhouse and on the UCSD Jacobs School of Engineering Dean’s Council of Advisors.
Christian Wildmoser
Board member
Born 1955. Board member since 2019. Member of the Renumeration Committee.
Education and work experience:
Doctor of Economics and has worked in banking for 25 years. He has been a partner of CVC Capital Partners for 16 years with responsibility for the operations in German-speaking Europe. Today, he is a private investor in growth companies.
Other assignments and positions:
Chairman of Waterdrop Microdrinks GmbH, board member of 1Drop SA, and Board of the African Parks Foundation Switzerland.
Shareholding in BICO:
B-shares: 318,492, Options: 40,000, Ownership: 0.64%, Voting right: 0.50%
Independent in relation to the company and group management and to the company’s major shareholders
